Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INCyst Trial
NCT05726786Phase 3Recruiting
- Sponsor
- Lausanne University Hospital
- Start
- Apr 2023
- Primary completion
- Aug 2026
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial (2 arms), sponsored by Lausanne University Hospital. Primary endpoint: Infectious complication after cystectomy at 30 days. Started Apr 2023; status: recruiting.
Beyond the preview
Go deeper on NCT05726786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05726786.